Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with diabetes or hypertension, raised albuminuria is independently associated with an increased risk of all mortality, cardiovascular morbidity and mortality, and renal insufficiency. The role of albuminuria in the general population is still controversial. We therefore undertook this study to examine the relationship between albuminuria and all-cause, cardiovascular disease (CVD) and non-CVD mortality in the general population. METHODS: Prospective population-based cohort study of 20 911 individuals aged 40-79 years recruited in 1993-1997 for the EPIC-Norfolk Study (UK) and followed-up for an average of 6.3 years. Random spot urine specimens were collected at baseline and the albumin-to-creatinine ratio measured. Participants were categorized into normoalbuminuria, microalbuminuria, and macroalbuminuria ordered groups. At follow-up, vital status and cause of death were obtained from the UK Office for National Statistics. RESULTS: During follow-up, 934 deaths were registered. Age-adjusted all-cause mortality rate increased significantly across categories of baseline albuminuria (5.3, 5.2, and 6.3/1000 person years (pyrs) across tertiles of normoalbuminuria, 8.7/1000 pyrs for microalbuminuria, and 18.4/1000 pyrs for macroalbuminuria, P < 0.001 for trend); CVD, 1.6, 1.7, 2.1, 4.3, 12.6/1000 pyrs (P < 0.001); and non-CVD, 3.7, 3.5, 4.2, 4.4, 5.8/1000 pyrs (P = 0.052) respectively. The multivariate hazard ratio for all-cause mortality associated with microalbuminuria was 1.48 (95% CI: 1.20, 1.79), and CVD 2.03 (95% CI: 1.55, 2.67). The association with non-CVD mortality was only significant in men. CONCLUSIONS: The significant increased risk of all-cause mortality especially from CVD associated with microalbuminuria, suggest that this may be a useful indicator in identifying those in the population at greatest absolute risk of fatal CVD events alongside conventional CVD risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In multiple epidemiological studies, moderately increased albuminuria is an independent risk marker for cardiovascular death (481-483).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [483]
In the citing paper
“Multiple epidemiologic studies have shown it to be an independent risk marker for cardiovascular death (325,337,338).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [338]
In the citing paper
“Albuminuria (formerly microalbuminuria) are a well-established cardiovascular risk marker, in which increases over time to macroalbuminuria (.300 mg/day) are associated with kidney disease and an increased risk for progression to endstage renal disease.”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [338]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 3×
“Coronary heart disease 0.2 (3) 0.6 (11) 0.6 ( 14 ) 1.3 (17) 3.9 (4) � 0.001”
InfluentialHillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551 · cited 4×
“Other vascular disease 0.9 ( 16 ) 0.5 (6) 0.9 (13) 1.3 (9) 3.8 (3) 0.105”
InfluentialEuropean cardiovascular disease statistics
Allender, S. E., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R., & Gray, A. M. (2008) · Deakin Research Online (Deakin University) · Cited by 1,459
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Essentials of medical statistics.
Kirkwood, B. R. (1988) · Blackwell Scientific Publications eBooks · Cited by 907
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
Yudkin, J., Forrest, R., & Jackson, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92657-8 · Cited by 847
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Bakris, G. L., Fonseca, V., Katholi, R. E., McGill, J. B., Messerli, F. H., Phillips, R. A., Raskin, P., Wright, J. T., Oakes, R., Lukas, M. A., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2227 · Cited by 792
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw, D., Parving, H.-H., & Henning, R. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050517 · Cited by 399
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Microalbuminuria and Cardiovascular Disease
Weir, M. R. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03190906 · Cited by 342
“Third Copenhagen City Heart Study (14) Residents of Copenhagen, Denmark, 30 to 70 yr, without coronary heart disease UAE 4.”
BackgroundChanges in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease
Schmieder, R. E., Mann, J. F. E., Schumacher, H., Gao, P., Mancia, G., Weber, M. A., McQueen, M., Koon, T., & Yusuf, S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010091001 · Cited by 270
Bakris, G. L., Fonseca, V., & Katholi, R. L. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.136 · Cited by 256
Halbesma, N., Kuiken, D.-S., Brantsma, A. H., Bakker, S. J. L., Wetzels, J. F. M., De Zeeuw, D., De Jong, P. E., & Gansevoort, R. T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121352 · Cited by 208
“n 6894 86 97 68 SBP (mmHg) baseline 128 (20) 151 (23) 127 (23) 142 (22) follow-up 127 (19) 143 (23) 125 (20) 134 (21) change 1.”
The global challenge of chronic kidney disease
Nahas, M. E. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00774.x · Cited by 200
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 205
Association of Albuminuria and Cancer Incidence
Jørgensen, L., Heuch, I., Jenssen, T., & Jacobsen, B. K. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060712 · Cited by 160
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening
Yamagata, K., Iseki, K., Nitta, K., Imai, H., Iino, Y., Matsuo, S., Makino, H., & Hishida, A. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0010-9 · Cited by 156
“Previous studies in general Western populations have suggested that microalbuminuria was a significant predictor for both coronary heart disease and stroke [70, 71].”
BackgroundChronic kidney disease in adults—UK guidelines for identification, management and referral
Vanholder, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl351 · Cited by 146
Watanabe, Y., & Tatsuno, I. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.50658 · Cited by 156
Masson, S., Latini, R., Milani, V., Moretti, L., Rossi, M. G., Carbonieri, E., Frisinghelli, A., Minneci, C., Valisi, M., Maggioni, A. P., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.881805 · Cited by 129
Maione, A., Navaneethan, S. D., Graziano, G., Mitchell, R. L., Johnson, D. W., Mann, J. F. E., Gao, P., Craig, J. C., Tognoni, G., Perkovic, V., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq792 · Cited by 123
“The relationships between increasing levels of albuminuria and the risks of death and cardiovascular events in diabetic and nondiabetic patients have long been established [4, 76, 108–119].”
BackgroundAssociation of Subcutaneous and Visceral Adiposity With Albuminuria: The Framingham Heart Study
Foster, M. C., Hwang, S., Massaro, J. M., Hoffmann, U., DeBoer, I., Robins, S. J., Vasan, R. S., & Fox, C. S. (2010) · Obesity · doi:10.1038/oby.2010.308 · Cited by 118
“2% of the adult population (1), and is associated with an increased risk of cardiovascular events (2,3), cardiovascular mortality (2,4,5) and all-cause mortality (3–5).”
BackgroundMicroalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
Sarafidis, P. A., & Bakris, G. L. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl309 · Cited by 112
“2 years, the presence of MA at baseline was independently associated with a significant greater risk of 36% for incident CHD [68], 49% for stroke [69], 103% for CV mortality and 48% for all-cause mortality [70].”
BackgroundNguyen, S. N., McCulloch, C. E., Brakeman, P., Portale, A. A., & Hsu, C. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3594 · Cited by 114
What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?
Yuyun, M. F., Adler, A. I., & Wareham, N. J. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165895.90748.3b · Cited by 105
Self-citationDobre, M. A., Yang, W. P., Pan‐Hammarström, Q., Appel, L. J., Bellovich, K. A., Chen, J., Feldman, H. I., Fischer, M. J., Ham, L. L., Hostetter, T. H., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001599 · Cited by 103
“In addition to progression to endstage disease, cardiovascular disease is the major cause of morbidity and mortality in patients with CKD.(2) Therefore, the need to identify novel risk factors that increase risk for cardiovascular disease in the setting of CKD has been well recognized.”
BackgroundInfluentialOmega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future
Watanabe, Y., & Tatsuno, I. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1333902 · Cited by 93
“Microalbuminuria is also recognized as an independent risk factor for CV morbidity and mortality in the general population [70,71].”
BackgroundAlbuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?
de Zeeuw, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09201.x · Cited by 102
Huang, N., Mao, E.-W., Hou, N., Liu, Y., Han, F., & Sun, X. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i4.115 · Cited by 100
Microalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes
Basi, S., & Lewis, J. D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.182 · Cited by 98
Jafar, T. H., Chaturvedi, N., Hatcher, J., & Levey, A. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm114 · Cited by 96
Impact of weight change on albuminuria in the general population
Bello, A. K., de Zeeuw, D., Nahas, M. E., Brantsma, A. H., Bakker, S. J. L., de Jong, P. E., & Gansevoort, R. T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm091 · Cited by 91
“In recent years increased levels of albuminuria are shown to predict cardiovascular disease progression in subjects with diabetes, or hypertension, but also in the general population [5, 6 ].”
BackgroundChristensson, A. G., Savage, C. J., Sjoberg, D. D., Cronin, A. M., O'Brien, M. F., Lowrance, W. T., Nilsson, P. M., Vickers, A. J., Russo, P., & Lilja, H. G. (2013) · International Journal of Cancer · doi:10.1002/ijc.28144 · Cited by 82
End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation
Lockhart, C., Hamilton, P., Quinn, C. E., & McVeigh, G. E. (2009) · Clinical Science · doi:10.1042/cs20080069 · Cited by 80
Darlington, O. T., Dickerson, C., Evans, M., McEwan, P. C., Sörstadius, E., Sugrue, D., van Haalen, H., & Sánchez, J. J. G. (2021) · Advances in Therapy · doi:10.1007/s12325-020-01607-4 · Cited by 78
Traditional and Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease
Vlagopoulos, P. T., & Sarnak, M. J. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.11.003 · Cited by 72
Correa‐Rotter, R., Naicker, S., Katz, I. J., Agarwal, S. K., Valdés, R. H., Kaseje, D. C. O., Rodríguez‐Iturbe, B., Shaheen, F. A. M., & Sitthi‐Amorn, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09208.x · Cited by 68
“Moreover, microalbuminuria is emerging as a useful marker to predict cardiovascular risk in the general populatio”
BackgroundInoue, K., Streja, E., Tsujimoto, T., & Kobayashi, H. H. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.12.004 · Cited by 64
Xu, J., Knowler, W. C., Devereux, R. B., Yeh, J. L., Umans, J. G., Begum, M., Fabsitz, R. R., & Lee, E. T. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.017 · Cited by 65
Wong, L. Y., Liew, A., Weng, W. T., Lim, C. K., Vathsala, A., & Toh, M. P. H. (2018) · International Journal of Nephrology · doi:10.1155/2018/5196285 · Cited by 64
O’Hare, A. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.129 · Cited by 59
Microalbuminuria and the metabolic syndrome and its components in the Chinese population
Lin, C., Liu, C.-S., Li, T., Chen, C., Li, C. ‐., & Lin, W. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01865.x · Cited by 62
Microalbuminuria: What Is It? Why Is It Important? What Should Be Done About It? An Update
Chugh, A. R., & Bakris, G. L. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06445.x · Cited by 58
Large Artery Stiffening as a Link Between Cerebral Lacunar Infarction and Renal Albuminuria
Hashimoto, J., Aikawa, T., & Imai, Y. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.291 · Cited by 55
Elajami, T. K., Alfaddagh, A., Lakshminarayan, D., Soliman, M. Y., Chandnani, M., & Welty, F. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004740 · Cited by 53
Outcomes Associated With Microalbuminuria
Kovesdy, C. P., Lott, E. H., Lü, J., Malakauskas, S. M., Ma, J. Z., Molnar, M. Z., & Kalantar‐Zadeh, K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.071 · Cited by 53
Xia, F., Liu, G., Shi, Y., & Zhang, Y. (2015) · Europe PMC (PubMed Central) · Cited by 50
Kidney Function, Proteinuria, and Cancer Incidence: The Korean Heart Study
Mok, Y., Matsushita, K., Ballew, S. H., Sang, Y., Jung, K. J., Lee, S., Jee, S. H., & Coresh, J. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.03.018 · Cited by 53
Liu, C.-S., Pi-Sunyer, X., Li, C.-I., Davidson, L. E., Li, T., Chen, W. W., Lin, C., Huang, C., & Lin, W.-Y. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.015 · Cited by 52
Hemodynamic Correlates of Proteinuria in Chronic Kidney Disease
Weir, M. R., Townsend, R. R., Fink, J. C., Teal, V. L., Anderson, C. A. M., Appel, L. J., Chen, J., He, J., Litbarg, N., OJO, A. O., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01670211 · Cited by 51
Munakata, M., Nunokawa, T., YOSHINAGA, K., & Toyota, T. (2006) · Hypertension Research · doi:10.1291/hypres.29.515 · Cited by 49
“It has been shown that microalbuminuria examined from one spot urine sample is well correlated with markers of inflammation (44) and predicts cardiovascular mortality (33) in the general population.”
BackgroundChanges in albuminuria and subsequent risk of incident kidney disease
Sumida, K., Molnar, M. Z., Potukuchi, P. K., George, K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02720317 · Cited by 47
Baweja, S., Kent, A. B., Masterson, R., Roberts, S., & Mcmahon, L. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.02960.x · Cited by 47
Onco-nephrology: an appraisal of the cancer and chronic kidney disease links
Izzedine, H., & Perazella, M. A. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu387 · Cited by 45
“[25] Prospective population-based cohort”
Albuminuria, Kidney Function, and Cancer Risk in the Community
Mok, Y., Ballew, S. H., Sang, Y., Coresh, J., Joshu, C. E., Platz, E. A., & Matsushita, K. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa043 · Cited by 44
Lessons Learned from Recent Hypertension Trials about Kidney Disease
Khosla, N., & Bakris, G. L. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00840805 · Cited by 47
“Antihypertensive Trials, CV Outcomes, and Microalbuminuria Whereas reductions in proteinuria ( 300 mg/d) are strongly associated with slowed progression of kidney disease, reductions in microalbuminuria ( 30 and 300 mg/d) correlate with decreased CV mortality (40,45,46).”
BackgroundScreening for chronic kidney disease in emerging countries: feasibility and hurdles
Perico, N., Bravo, R. F., León, F. R. D., & Remuzzi, G. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp039 · Cited by 44
Watanabe, Y., & Tatsuno, I. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1863784 · Cited by 46
Polkinghorne, K. R., Su, Q., Chadban, S. J., Shaw, J. E., Zimmet, P., & Atkins, R. C. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.034 · Cited by 43
Marti, F., Vollenweider, P., Marques-Vidal, P. M., Mooser, V., Waeber, G., Paccaud, F. M., & Bochud, M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-733 · Cited by 46
“As albuminuria is an established marker of kidney damage in diabetic and nondiabetic individuals and a strong predictor of cardiovascular morbidity and mortality [15,16], a better understanding of the determinants of albuminuria is therefore of great interest.”
BackgroundChang, H., Lee, P., Lei, C., Tung, C., Hsu, Y., Huang, T., Lu, L.-C., & Lin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061450 · Cited by 42
Microalbuminuria: Risk factor and potential therapeutic target for stroke?
Ovbiagele, B. I. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.007 · Cited by 48
Central Obesity and Albuminuria: Both Cross-Sectional and Longitudinal Studies in Chinese
Lin, W., Pi-Sunyer, X., Liu, C.-S., Li, C.-I., Davidson, L. E., Li, T., & Lin, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047960 · Cited by 41
“Albuminuria is an early marker of vascular dysfunction and renal disease which has been linked to an increased risk for future cardiovascular disease, ESRD, and cardiovascular disease (CVD)/all-cause mortality [2,3,4,5].”
BackgroundDetection and measurement of urinary protein
Polkinghorne, K. R. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000247502.49044.10 · Cited by 40
Tsao, K., Wu, T., Chang, P.-Y., Sun, C., Wu, L., & Wu, J. T. (2007) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20215 · Cited by 38
“For example, hypertensive or diabetic individuals with microalbuminuria have frequently been found to be at risk for not only the CVDs but also carcinogenesis (19).”
BackgroundMicroalbuminuria and cardiorenal risk: old and new evidence in different populations
Márquez, D. F., Ruiz‐Hurtado, G., Segura, J., & Ruilope, L. M. (2019) · F1000Research · doi:10.12688/f1000research.17212.1 · Cited by 41
Ripley, E. B. D. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.04.008 · Cited by 37
de Boer, I. H., Astor, B. C., Kramer, H., Palmas, W., Rudser, K. D., Seliger, S. L., Shlipak, M. G., Siscovick, D. S., Tsai, M. Y., & Kestenbaum, B. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.018 · Cited by 39
“[3] Yuyun MF, Khaw KT, Luben R, et al.”
BackgroundXu, J., Lee, E. T., Devereux, R. B., Umans, J. G., Bella, J. N., Shara, N. M., Yeh, J. L., Fabsitz, R. R., & Howard, B. V. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.010 · Cited by 36
Kim, T. N., Lee, E. J., Hong, J. W., Kim, J. M., Won, J. C., Kim, M.-K., Noh, J. H., Ko, K. S., Rhee, B. D., & Kim, D. (2016) · Medicine · doi:10.1097/md.0000000000002500 · Cited by 33
“INTRODUCTION A lbuminuria is associated with an increased risk of all-cause mortality and cardiovascular morbidity and mortality in patients with type 2 diabetes or hypertension as well as in the general population.(1,2) Even microalbuminuria is regarded as a risk factor for the progression of chronic kidney disease (…”
BackgroundWang, J., Wang, Y., Li, Y., Hu, Y., Jin, L., Wang, W., Wang, W., Gao, Z., Tang, X., Wan, Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.864562 · Cited by 35
Wang, Y., Zhao, P. F., Chu, C., Du, M., Zhang, X., Zou, T., Hu, G., Zhou, H., Jia, H., Liao, Y., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18658 · Cited by 30
Schernthaner, G.-H. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02025.x · Cited by 34
Hypertension and Diabetes—A Toxic Combination
Bell, D. S. H. (2008) · Endocrine Practice · doi:10.4158/ep.14.8.1031 · Cited by 32
Wu, T., McGrath, K. C. Y., & Death, A. K. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.2005.1.4.309 · Cited by 30
Bell, R. M., Rear, R., Cunningham, J., Dawnay, A., & Yellon, D. M. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0637-3 · Cited by 27
Ko, G. T. C., So, W. Y., Chan, N. N., Chan, W. ‐., Tong, P. C. Y., Li, J., Yeung, M. W., Chow, C. C., Ozaki, R., Ronald, C. W., et al. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00475.x · Cited by 27
Ishimitsu, T., Kobayashi, T., Honda, T., Takahashi, M., Minami, J., Ohta, S., Inada, H., Yoshii, M., Ono, H., & Matsuoka, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.351 · Cited by 27
Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease
Moisi, M. I., BUNGAU, S. G., Vesa, C. M., Diaconu, C. C., Behl, T., Stoicescu, M., Toma, M. M., Bustea, C., Sava, C. N., & Popescu, M. I. (2021) · Diagnostics · doi:10.3390/diagnostics11081518 · Cited by 29
“25,112 Fatal and stable CAD Microalbuminuria is useful in detecting subjects with high risk of CAD development [95]”
BackgroundAni, C., & Ovbiagele, B. I. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.020 · Cited by 26
“On the other hand, a large (N20,000 subjects) general population study showed urinary protein excretion to be independently related to all-cause mortality after 6 years [39] and a small (n=60) single center study related microalbuminuria to mortality 1year after stroke [11].”
Maahs, D. M., Snell‐Bergeon, J. K., Kinney, G. L., Wadwa, R. P., Garg, S. K., Ogden, L. G., & Rewers, M. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.04.004 · Cited by 26
Hoseini, V. N., & Rasouli, M. (2009) · PubMed · Cited by 29
Zhang, A., Li, M., Qiu, J., Sun, J., Su, Y., Cai, S., Bao, Q., Cheng, B., Ma, S., Zhang, Y., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-021-02644-z · Cited by 24
“In all subjects Among them, compared with participants with normal albuminuria, individuals with microalbuminuria increased the risk of all-cause death by about 50%, and the risk of death from cardiovascular disease increased by about twice [17].”
BackgroundAlbuminuria, Just a Marker for Cardiovascular Disease, Or Is It More?
de Zeeuw, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050524 · Cited by 25
Wang, Y., Li, F., Chu, C., Zhang, X., Zhang, X., Liao, Y., Du, M., Zou, T., Ma, Q., Chen, C., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101420 · Cited by 22
Correa‐Rotter, R., & Gonzalez-Michaca, L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09813.x · Cited by 24
Predictors of urinary albumin excretion in women with polycystic ovary syndrome
Dulęba, A. J., & Ahmed, I. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.120 · Cited by 21
“Excessive UEA is considered to be a risk factor for all-cause mortality and cardiovascular morbidity (13,14).”
BackgroundNoborisaka, Y., Ishizaki, M., Nakata, M., Yamada, Y., Honda, R., Yokoyama, H., Miyao, M., & Tabata, M. (2011) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-011-0234-x · Cited by 21
Lee, C.-T. C., Adler, A., Forouhi, N. G., Luben, R., Welch, A. A., Khaw, K., Bingham, S. A., & Wareham, N. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.307 · Cited by 22
Jafar, T. H., Qadri, Z., & Hashmi, S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp042 · Cited by 21
“However, MA has been associated with CVD mortality in other populations, and our findings of the link between MA and major ECG changes suggest that the same is likely to apply to Indo-Asians as well [23].”
BackgroundMishra, V. V., Goyal, P. A., Priyankur, R., Choudhary, S., Aggarwal, R. S., Gandhi, K., Vyas, B., & Hokabaj, S. (2016) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-016-0950-7 · Cited by 20
Prevalence and distribution of (micro)albuminuria in toddlers
Gracchi, V., van den Belt, S. M., Küpers, L. K., Corpeleijn, E., de Zeeuw, D., & Heerspink, H. J. L. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv407 · Cited by 20
“Most adult studies use a creatinine-corrected urinary albumin concentration as the optimal representation for describing the amount of albumin leakage [7, 20].”
Refaie, A. F. A., Baldassini, L., Mondillo, C., Ceccarelli, E., Tarquini, R., Gennari, L., Gonnelli, S., & Caffarelli, C. (2024) · Endocrine · doi:10.1007/s12020-024-04085-8 · Cited by 18
Nakamura, Y., Kobayashi, H. H., Tanaka, S., Hatanaka, Y., Fukuda, N., & Abe, M. (2021) · Clinical Endocrinology · doi:10.1111/cen.14434 · Cited by 18
Oliveras, A., Armario, P., Sierra, C., Arroyo, J. A., HERNANDEZDELREY, R., Vazquez, S., Larrousse, M., Sans, L., Roca-Cusachs, A., & de la Sierra, A. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt074 · Cited by 20
Chen, Y., Hong, L., Loh, T. P., Liu, Q., Teo, T. L., Lee, T. K., & Sethi, S. K. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0969 · Cited by 19
Wu, T., Chang, P.-Y., Li, C.-C., Tsao, K., Sun, C., & Wu, J. T. (2005) · PubMed · Cited by 18
Fukami, A., Adachi, H., Hirai, Y., Enomoto, M., Otsuka, M., Kumagai, E., Nakamura, S., Yoshimura, A., Obuchi, A., Nohara, Y., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.033 · Cited by 19
Lee, S.-H., Kim, D., Kim, Y., Roh, Y. K., Ju, S.-Y., Nam, H.-Y., Nam, G. E., Choi, J.-S., Lee, J.-E., Sang, J.-E., et al. (2016) · Medicine · doi:10.1097/md.0000000000003224 · Cited by 21
“Albuminuria is also a risk factor for CVD, and excess urinary albumin is related to increased all-cause mortality.(4,5) In patients with HTN, urinary albumin leakage has been used as a marker of cardiovascular complications and a reliable predictor of ischemic heart disease.”
BackgroundCystatin C: A Marker for Inflammation and Renal Function Among HIV-infected Children and Adolescents
Deyà‐Martínez, À., Fortuny, C., Soler‐Palacín, P., Neth, O., Sánchez, E., Martín‐Nalda, A., Falcón-Neyra, L., Vila, A., Valls, A., & Noguera‐Julián, A. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000960 · Cited by 17
“In HIVinfected adults, inflammatory activity has been implicated as a cause in the development of microalbuminuria,(41) which, in turn, is a well-known risk factor for kidney and cardiovascular disease in both HIV-infected(42,43) and uninfected individuals.(44) Again, low numbers and lack of significant renal disease…”
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis
Mok, Y., Surapaneni, A., Sang, Y., Coresh, J., Grams, M. E., Matsushita, K., Ballew, S. H., de Pinho, N. A., Ärnlöv, J., Barreto, S. M., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03140-z · Cited by 16
Séjil, S., Janand-Delenne, B., Aviérinos, J.-F., Habib, G., Labastie, N., Raccah, D., Vague, P., & Lassmann-Vague, V. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01992.x · Cited by 16
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT
Chen, D. P., Davis, B. R., Simpson, L. M., Cushman, W. C., Cutler, J. A., Dobre, M. A., Ford, C. E., Louis, G. T., Muntner, P., Oparil, S., et al. (2016) · Clinical Nephrology · doi:10.5414/cn108949 · Cited by 16
“Some, but not all, studies demonstrate an association between higher levels of urinary albumin-creatinine ratio and cancer incidence [16, 17, 18].”
Solbu, M. D., Jenssen, T. G., Eriksen, B. O., & Toft, I. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.016 · Cited by 18
“Microalbuminuria (MA) is an independent risk factor for cardiovascular disease (CVD), mortality, and nephropathy in diabetic populations [1,2], nondiabetic hypertensives [3,4], as well as in general and nondiabetic, nonhypertensive populations [5-7].”
Background
Metadata
- Authors
- Yuyun, M. F.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Yuyun, M. F
- ORCID
- Yuyun, M. F
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 33
- Issue
- 1
- Pages
- 189-198
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2154093137
- Semantic Scholar
- bcde3de3293fcf49844bd54d3397199bc1f731b1
- Cited by
- 192
- References
- 46
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation
- Stroke Association
- Medical Research Council
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- microalbuminuria, albuminuria, macroalbuminuria, all-cause mortality, cardiovascular mortality, non-CVD mortality, albumin-creatinine ratio, urinary albumin, general population, EPIC-Norfolk study, mortality prediction, sex differences in mortality, cardiovascular risk
- MeSH terms
- Adult, Aged, Albuminuria, Cardiovascular Diseases, Cause of Death, Female, United Kingdom, Humans, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Prevalence, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.